ALK and inflammatory myofibroblastic tumor: TPM3-ALK and TPM4-ALK, which are fusion proteins consisting of the N-terminus of TPM and the C-terminal kinase domain of ALK, have been reported in patients with inflammatory myofibroblastic tumors, with TPM3-ALK being the most frequently observed (Lawrence et al., 2000).